Is your organization missing from this list? Reach out to Leyla Cakici, Strategic Alliance Partnership Manager, to learn more about the complimentary strategic partnership program: lcakici@mjhlifesciences.com
Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC
‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis
FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer
Education and Inspiration Across the Cancer Journey